{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:16:40Z","timestamp":1759990600201,"version":"3.41.2"},"reference-count":361,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323855488"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008899","name":"University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R01MH101130"],"award-info":[{"award-number":["1R01MH101130"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R01061200","1R01AG054839"],"award-info":[{"award-number":["1R01061200","1R01AG054839"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.vh.2020.12.012","type":"book-chapter","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T04:27:45Z","timestamp":1613622465000},"page":"265-316","source":"Crossref","is-referenced-by-count":1,"title":["Alterations in cyclic nucleotide signaling are implicated in healthy aging and age-related pathologies of the brain"],"prefix":"10.1016","member":"78","reference":[{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13041-019-0456-1","article-title":"Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice","volume":"12","author":"Abd-Elrahman","year":"2019","journal-title":"Molecular Brain"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0304-3940(01)02214-5","article-title":"Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease","volume":"312","author":"Abe","year":"2001","journal-title":"Neuroscience Letters"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.0000000000000037","article-title":"PET imaging shows loss of striatal PDE10A in patients with Huntington disease","volume":"82","author":"Ahmad","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0025","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-190849","article-title":"Granisetron alleviates Alzheimer's disease pathology in TgSwDI mice through calmodulin-dependent protein kinase II\/cAMP-response element binding protein pathway","volume":"72","author":"Al Rihani","year":"2019","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.vh.2020.12.012_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.physbeh.2015.05.029","article-title":"Paradoxical role of PKA inhibitor on amyloid beta-induced memory deficit","volume":"149","author":"Amini","year":"2015","journal-title":"Physiology & Behavior"},{"key":"10.1016\/bs.vh.2020.12.012_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2017.06.116","article-title":"Neurogenesis in the aging brain","volume":"141","author":"Apple","year":"2017","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/JGP.0b013e31819431ea","article-title":"A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: Pilot follow-up study","volume":"17","author":"Arai","year":"2009","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s43440-020-00060-y","article-title":"Ameliorative effects of a phosphodiesterase 10A inhibitor, MR1916 on L-DOPA-induced dyskinesia in parkinsonian rats","volume":"72","author":"Arakawa","year":"2020","journal-title":"Pharmacological Reports"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(95)01117-X","article-title":"Age-related changes in bindings of second messengers in the rat brain","volume":"704","author":"Araki","year":"1995","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","article-title":"Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice","volume":"17","author":"Arendash","year":"2009","journal-title":"Journal of Alzheimer's Disease"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-4159.2007.04704.x","article-title":"High intracellular concentrations of amyloid-beta block nuclear translocation of phosphorylated CREB","volume":"103","author":"Arvanitis","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2020.12.012_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0169-328X(96)00098-8","article-title":"Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor","volume":"41","author":"Asanuma","year":"1996","journal-title":"Brain Research. Molecular Brain Research"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02432185","article-title":"Studies in aging of the brain. V. Reduced norepinephrine, dopamine, and cyclic AMP in rat brain with advancing age","volume":"1","author":"Austin","year":"1978","journal-title":"AGE"},{"key":"10.1016\/bs.vh.2020.12.012_bb0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fncel.2014.00376","article-title":"Intermingled cAMP, cGMP and calcium spatiotemporal dynamics in developing neuronal circuits","volume":"8","author":"Averaimo","year":"2014","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"14","key":"10.1016\/bs.vh.2020.12.012_bb0085","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/mds.26345","article-title":"A novel mutation of PDE8B Gene in a Japanese family with autosomal-dominant striatal degeneration","volume":"30","author":"Azuma","year":"2015","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0090","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1073\/pnas.96.9.5280","article-title":"Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway","volume":"96","author":"Bach","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb0095","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-019-0033-4","article-title":"Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: Inhibition and beyond","volume":"18","author":"Baillie","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/nbdi.2002.0492","article-title":"Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells","volume":"10","author":"Baltrons","year":"2002","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nbd.2004.07.022","article-title":"Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains","volume":"17","author":"Baltrons","year":"2004","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.vh.2020.12.012_bb0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.exger.2017.10.023","article-title":"The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA\/CaMKII\/CREB signaling","volume":"100","author":"Baluchnejadmojarad","year":"2017","journal-title":"Experimental Gerontology"},{"issue":"Pt. 1","key":"10.1016\/bs.vh.2020.12.012_bb0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3110045","article-title":"The secreted form of the Alzheimer's beta-amyloid precursor protein stimulates a membrane-associated guanylate cyclase","volume":"311","author":"Barger","year":"1995","journal-title":"The Biochemical Journal"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1179\/135100001101536436","article-title":"Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat","volume":"6","author":"Barthwal","year":"2001","journal-title":"Redox Report"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13195-018-0352-4","article-title":"Amyloid beta-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition","volume":"10","author":"Bartolome","year":"2018","journal-title":"Alzheimer's Research & Therapy"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0130","first-page":"591","article-title":"cAMP-inhibits cytoplasmic phospholipase A(2) and protects neurons against amyloid-beta-induced synapse damage","volume":"4","author":"Bate","year":"2015","journal-title":"Biology (Basel)"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0135","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mds.27341","article-title":"A selective phosphodiesterase 10A inhibitor reduces L-Dopa-induced dyskinesias in parkinsonian monkeys","volume":"33","author":"Beck","year":"2018","journal-title":"Movement Disorders"},{"issue":"5\u20136","key":"10.1016\/bs.vh.2020.12.012_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0047-6374(75)90038-X","article-title":"Effects of electrical stimulation and norepinephrine on cyclic-AMP levels in the cerebral cortex of the aging rat","volume":"4","author":"Berg","year":"1975","journal-title":"Mechanisms of Ageing and Development"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb0150","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2174\/1389203721666200206161912","article-title":"The interplay between depression and Parkinson's disease: Learning the link through Ca2+\/cAMP signalling","volume":"21","author":"Bergantin","year":"2020","journal-title":"Current Protein & Peptide Science"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0155","first-page":"651","article-title":"Age associated changes in intracellular cyclic adenosine monophosphate","volume":"55","author":"Birkenfeld","year":"1984","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neurobiolaging.2019.01.014","article-title":"Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: A double-blind placebo-controlled study","volume":"77","author":"Blokland","year":"2019","journal-title":"Neurobiology of Aging"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2020.12.012_bb0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(99)01444-4","article-title":"Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing","volume":"834","author":"Blum-Degen","year":"1999","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02260966","article-title":"NADPH-diaphorase\/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen","volume":"7","author":"Bockelmann","year":"1994","journal-title":"Journal of Neural Transmission. Parkinson's Disease and Dementia Section"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0006-8993(98)01307-9","article-title":"A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits","volume":"818","author":"Bonkale","year":"1999","journal-title":"Brain Research"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2020.12.012_bb0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-8993(96)00724-X","article-title":"Impaired G-protein-stimulated adenylyl cyclase activity in Alzheimer's disease brain is not accompanied by reduced cyclic-AMP-dependent protein kinase A activity","volume":"737","author":"Bonkale","year":"1996","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11323-O","article-title":"Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease","volume":"187","author":"Bonkale","year":"1995","journal-title":"Neuroscience Letters"},{"issue":"Suppl. 1","key":"10.1016\/bs.vh.2020.12.012_bb0190","first-page":"S252","article-title":"Phosphodiesterase inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0169-328X(98)00069-2","article-title":"Vasopressin-induction of the immediate early gene, NGFI-A, in cultured hippocampal glial cells","volume":"57","author":"Brinton","year":"1998","journal-title":"Brain Research. Molecular Brain Research"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.parkreldis.2011.07.003","article-title":"cGMP level in idiopathic Parkinson's disease patients with and without cardiovascular disease\u2014A pilot study","volume":"17","author":"Brodacki","year":"2011","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/bs.vh.2020.12.012_bb0205","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.biopsych.2009.01.032","article-title":"Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide\/C-terminal endothelin-1 precursor fragment ratio","volume":"65","author":"Buerger","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.vh.2020.12.012_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mad.2017.08.001","article-title":"Investigating the amyloid-beta enhancing effect of cGMP in neuro2a cells","volume":"166","author":"Calcagno","year":"2017","journal-title":"Mechanisms of Ageing and Development"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/2211-5463.12156","article-title":"Selective inhibition of phosphodiesterases 4, 5 and 9 induces HSP20 phosphorylation and attenuates amyloid beta 1-42-mediated cytotoxicity","volume":"7","author":"Cameron","year":"2017","journal-title":"FEBS Open Bio"},{"issue":"13","key":"10.1016\/bs.vh.2020.12.012_bb0220","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.1322360111","article-title":"cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex","volume":"111","author":"Carlyle","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02815141","article-title":"cAMP-dependent protein kinase in cerebral microvessels in aging and Alzheimer disease","volume":"26","author":"Cashman","year":"1995","journal-title":"Molecular and Chemical Neuropathology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fnins.2020.00466","article-title":"Phosphodiesterase 9A inhibition facilitates corticostriatal transmission in wild-type and transgenic rats that model Huntington's disease","volume":"14","author":"Chakroborty","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0235","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuint.2007.02.002","article-title":"The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice","volume":"50","author":"Chalimoniuk","year":"2007","journal-title":"Neurochemistry International"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2004.09.028","article-title":"Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced Parkinsonism in mice","volume":"324","author":"Chalimoniuk","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0245","first-page":"647","article-title":"Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients","volume":"56","author":"Chalimoniuk","year":"2004","journal-title":"Polish Journal of Pharmacology"},{"issue":"1\u20133","key":"10.1016\/bs.vh.2020.12.012_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02815117","article-title":"Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide","volume":"35","author":"Chalimoniuk","year":"1998","journal-title":"Molecular and Chemical Neuropathology"},{"issue":"33","key":"10.1016\/bs.vh.2020.12.012_bb0255","doi-asserted-by":"crossref","first-page":"11390","DOI":"10.1523\/JNEUROSCI.0757-12.2012","article-title":"Alzheimer's beta-secretase (BACE1) regulates the cAMP\/PKA\/CREB pathway independently of beta-amyloid","volume":"32","author":"Chen","year":"2012","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12989","article-title":"Aging-induced Akt activation involves in aging-related pathologies and Abeta-induced toxicity","volume":"18","author":"Chen","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/bs.vh.2020.12.012_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2013.04.027","article-title":"Neuronal expression of soluble adenylyl cyclase in the mammalian brain","volume":"1518","author":"Chen","year":"2013","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00213-010-1943-3","article-title":"Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25-35 or Abeta1-40 peptide in rats","volume":"212","author":"Cheng","year":"2010","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0275","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0280","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuroscience.2008.03.038","article-title":"Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice","volume":"153","author":"Costa","year":"2008","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0285","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.neurobiolaging.2006.04.009","article-title":"Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms","volume":"28","author":"Costa","year":"2007","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0290","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1471-4159.1992.tb11357.x","article-title":"Adenylyl cyclase activity in postmortem human brain: Evidence of altered G protein mediation in Alzheimer's disease","volume":"58","author":"Cowburn","year":"1992","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0304-3940(92)90324-Z","article-title":"Preservation of Gi-protein inhibited adenylyl cyclase activity in the brains of patients with Alzheimer's disease","volume":"141","author":"Cowburn","year":"1992","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0300","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/npp.2016.163","article-title":"A First-In-Class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer's disease mice","volume":"42","author":"Cuadrado-Tejedor","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/bs.vh.2020.12.012_bb0305","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1476-5381.2011.01517.x","article-title":"Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease","volume":"164","author":"Cuadrado-Tejedor","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fnagi.2019.00149","article-title":"Taking advantage of the selectivity of histone deacetylases and phosphodiesterase inhibitors to design better therapeutic strategies to treat Alzheimer's disease","volume":"11","author":"Cuadrado-Tejedor","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0315","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1523\/JNEUROSCI.3453-12.2013","article-title":"HDAC inhibition facilitates the switch between memory systems in young but not aged mice","volume":"33","author":"Dagnas","year":"2013","journal-title":"The Journal of Neuroscience"},{"issue":"7","key":"10.1016\/bs.vh.2020.12.012_bb0320","doi-asserted-by":"crossref","first-page":"670 e671","DOI":"10.1016\/j.amjmed.2011.02.027","article-title":"Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults","volume":"124","author":"Daniels","year":"2011","journal-title":"The American Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-019-1683-1","article-title":"Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex","volume":"17","author":"Datta","year":"2020","journal-title":"Journal of Neuroinflammation"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0330","doi-asserted-by":"crossref","first-page":"M95","DOI":"10.1093\/gerona\/51A.3.M95","article-title":"Atrial natriuretic peptide levels in the elderly: Differentiating normal aging changes from disease","volume":"51","author":"Davis","year":"1996","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0335","doi-asserted-by":"crossref","first-page":"1017 e1011","DOI":"10.1016\/j.neurobiolaging.2011.09.033","article-title":"A genome-wide scan for common variants affecting the rate of age-related cognitive decline","volume":"33","author":"De Jager","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0340","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuropharm.2008.06.025","article-title":"Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats","volume":"55","author":"de Lima","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0345","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cnur.2017.04.009","article-title":"Impaired sleep: A multifaceted geriatric syndrome","volume":"52","author":"Dean","year":"2017","journal-title":"The Nursing Clinics of North America"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0350","first-page":"101","article-title":"Phosphodiesterase inhibition facilitates cognitive restoration in rodent models of age-related memory decline","volume":"34","author":"Devan","year":"2014","journal-title":"NeuroRehabilitation"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0355","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-8993(90)90168-B","article-title":"Selective alterations of high affinity [3H]forskolin binding sites in Alzheimer's disease: A quantitative autoradiographic study","volume":"511","author":"Dewar","year":"1990","journal-title":"Brain Research"},{"key":"10.1016\/bs.vh.2020.12.012_bb0360","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2008.02.108","article-title":"The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging","volume":"1216","author":"Domek-Lopacinska","year":"2008","journal-title":"Brain Research"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb0365","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/gerona\/glw078","article-title":"Relationships between caffeine intake and risk for probable dementia or global cognitive impairment: The women's health initiative memory study","volume":"71","author":"Driscoll","year":"2016","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"1\u20133","key":"10.1016\/bs.vh.2020.12.012_bb0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2010.02.036","article-title":"Etazolate improves performance in a foraging and homing task in aged rats","volume":"634","author":"Drott","year":"2010","journal-title":"European Journal of Pharmacology"},{"issue":"12 Pt. A","key":"10.1016\/bs.vh.2020.12.012_bb0375","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.bbadis.2013.03.004","article-title":"Cyclophilin D deficiency rescues Abeta-impaired PKA\/CREB signaling and alleviates synaptic degeneration","volume":"1842","author":"Du","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1535370219894558","article-title":"Angelica polysaccharide ameliorates memory impairment in Alzheimer's disease rat through activating BDNF\/TrkB\/CREB pathway","volume":"245","author":"Du","year":"2020","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"issue":"7","key":"10.1016\/bs.vh.2020.12.012_bb0385","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.neuint.2012.07.017","article-title":"In vivo hippocampal microdialysis reveals impairment of NMDA receptor-cGMP signaling in APP(SW) and APP(SW)\/PS1(L166P) Alzheimer's transgenic mice","volume":"61","author":"Duszczyk","year":"2012","journal-title":"Neurochemistry International"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0390","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.neuroscience.2005.06.057","article-title":"Endogenous beta-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells","volume":"135","author":"Echeverria","year":"2005","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0395","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbr.2011.08.015","article-title":"Inhibition of PKA attenuates memory deficits induced by beta-amyloid (1-42), and decreases oxidative stress and NF-kappaB transcription factors","volume":"226","author":"Eftekharzadeh","year":"2012","journal-title":"Behavioural Brain Research"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203837","article-title":"Cilostazol disrupts TLR-4, Akt\/GSK-3beta\/CREB, and IL-6\/JAK-2\/STAT-3\/SOCS-3 crosstalk in a rat model of Huntington's disease","volume":"13","author":"El-Abhar","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2020.12.012_bb0405","doi-asserted-by":"crossref","first-page":"112004","DOI":"10.1016\/j.bbr.2019.112004","article-title":"The efficacy and underlying mechanism of phosphodiesterase- 5 inhibitors in preventing cognitive impairment and Alzheimer pathology: A systematic review of animal studies","volume":"372","author":"El-Bakly","year":"2019","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.vh.2020.12.012_bb0410","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroscience.2015.07.087","article-title":"Alterations in CA1 pyramidal neuronal intrinsic excitability mediated by Ih channel currents in a rat model of amyloid beta pathology","volume":"305","author":"Eslamizade","year":"2015","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0415","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1007\/s12035-017-0690-4","article-title":"Early preclinical changes in hippocampal CREB-binding protein expression in a mouse model of familial Alzheimer's disease","volume":"55","author":"Ettcheto","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"51","key":"10.1016\/bs.vh.2020.12.012_bb0420","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1523\/JNEUROSCI.4986-08.2008","article-title":"Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects","volume":"28","author":"Favilla","year":"2008","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0425","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/mds.27963","article-title":"PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression","volume":"35","author":"Fazio","year":"2020","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044569","article-title":"Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes","volume":"7","author":"Feinkohl","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0435","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11011-018-0374-4","article-title":"Roflumilast ameliorates cognitive impairment in APP\/PS1 mice via cAMP\/CREB\/BDNF signaling and anti-neuroinflammatory effects","volume":"34","author":"Feng","year":"2019","journal-title":"Metabolic Brain Disease"},{"issue":"17","key":"10.1016\/bs.vh.2020.12.012_bb0440","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1093\/hmg\/dds216","article-title":"Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells","volume":"21","author":"Feyeux","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0445","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","article-title":"The psychosis spectrum in Parkinson disease","volume":"13","author":"Ffytche","year":"2017","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0450","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejmech.2012.12.009","article-title":"Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease","volume":"60","author":"Fiorito","year":"2013","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"21","key":"10.1016\/bs.vh.2020.12.012_bb0455","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1021\/acs.jmedchem.7b00979","article-title":"Identification of a novel 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine analogue as a potent phosphodiesterase 5 inhibitor with improved aqueous solubility for the treatment of Alzheimer's disease","volume":"60","author":"Fiorito","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0460","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000065431","article-title":"Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells","volume":"11","author":"Fiscus","year":"2002","journal-title":"Neurosignals"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0465","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: Molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiological Reviews"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0470","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbrc.2016.12.140","article-title":"Maturation and processing of the amyloid precursor protein is regulated by the potassium\/sodium hyperpolarization-activated cyclic nucleotide-gated ion channel 2 (HCN2)","volume":"483","author":"Frykman","year":"2017","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2\u20133","key":"10.1016\/bs.vh.2020.12.012_bb0475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0047-6374(90)90131-X","article-title":"Altered post-receptorial signal transduction mechanism under various stimulation in polymorphonuclear granulocytes of Alzheimer's disease","volume":"52","author":"Fulop","year":"1990","journal-title":"Mechanisms of Ageing and Development"},{"issue":"11","key":"10.1016\/bs.vh.2020.12.012_bb0480","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/j.1460-9568.2006.04816.x","article-title":"Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease","volume":"23","author":"Galati","year":"2006","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.vh.2020.12.012_bb0485","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2012.06.052","article-title":"Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD","volume":"64","author":"Garcia-Barroso","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0490","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-5793(97)00753-9","article-title":"Potential CRE suppression by familial Alzheimer's mutants of APP independent of adenylyl cyclase regulation","volume":"412","author":"Giambarella","year":"1997","journal-title":"FEBS Letters"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013417","article-title":"Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington's disease","volume":"5","author":"Giampa","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0500","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nbd.2009.02.014","article-title":"Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease","volume":"34","author":"Giampa","year":"2009","journal-title":"Neurobiology of Disease"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0505","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0510","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1460-9568.2008.06387.x","article-title":"Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: New aspects in the pathogenetic mechanisms","volume":"28","author":"Giorgi","year":"2008","journal-title":"The European Journal of Neuroscience"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0515","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0197-0186(94)90026-4","article-title":"Activities of 3':5' cyclic nucleotide phosphodiesterases in the superior cervical ganglion of rat: Characterization, compartmentalization and observations in young and old animals","volume":"25","author":"Giorgi","year":"1994","journal-title":"Neurochemistry International"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0520","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0525","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","article-title":"Cognitive dysfunction in Huntington's disease: Humans, mouse models and molecular mechanisms","volume":"1","author":"Giralt","year":"2012","journal-title":"Journal of Huntington's Disease"},{"issue":"8","key":"10.1016\/bs.vh.2020.12.012_bb0530","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus"},{"issue":"21","key":"10.1016\/bs.vh.2020.12.012_bb0535","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","article-title":"Increased PKA signaling disrupts recognition memory and spatial memory: Role in Huntington's disease","volume":"20","author":"Giralt","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.vh.2020.12.012_bb0540","doi-asserted-by":"crossref","first-page":"107899","DOI":"10.1016\/j.neuropharm.2019.107899","article-title":"GW9508 ameliorates cognitive impairment via the cAMP-CREB and JNK pathways in APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"164","author":"Gong","year":"2020","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/bs.vh.2020.12.012_bb0545","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0550","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0197-4580(94)90151-1","article-title":"Increased accumulation of cAMP in cerebral microvessels in Alzheimer's disease","volume":"15","author":"Grammas","year":"1994","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0555","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/BST20160396","article-title":"Cross-talk between LRRK2 and PKA: Implication for Parkinson's disease?","volume":"45","author":"Greggio","year":"2017","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/bs.vh.2020.12.012_bb0560","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2018.06.002","article-title":"Sub-efficacious doses of phosphodiesterase 4 and 5 inhibitors improve memory in a mouse model of Alzheimer's disease","volume":"138","author":"Gulisano","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0565","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjcard.2006.02.062","article-title":"Relation of brain natriuretic peptide levels to cognitive dysfunction in adults >55 years of age with cardiovascular disease","volume":"98","author":"Gunstad","year":"2006","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0570","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.01.004","article-title":"FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP\/PS1 transgenic mice via cAMP\/PKA\/CREB signaling and anti-inflammatory effects","volume":"116","author":"Guo","year":"2017","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0575","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2967\/jnumed.116.180497","article-title":"Longitudinal small-animal PET imaging of the zQ175 mouse model of Huntington Disease shows in vivo changes of molecular targets in the striatum and cerebral cortex","volume":"58","author":"Haggkvist","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0580","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41598-017-00614-w","article-title":"Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson's disease model","volume":"7","author":"Ham","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0585","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0306-4522(92)90067-C","article-title":"Effects of aging on signal transmission and transduction systems in the gerbil brain: Morphological and autoradiographic study","volume":"46","author":"Hara","year":"1992","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0590","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/syn.10067","article-title":"Age differences in phosphodiesterase type-IV and its functional response to dopamine D1 receptor modulation in the living brain: A PET study in conscious monkeys","volume":"44","author":"Harada","year":"2002","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0595","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/jpet.116.237388","article-title":"TAK-063, a novel phosphodiesterase 10A inhibitor, protects from striatal neurodegeneration and ameliorates behavioral deficits in the R6\/2 mouse model of Huntington's disease","volume":"360","author":"Harada","year":"2017","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.vh.2020.12.012_bb0600","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fnins.2019.00837","article-title":"Phosphodiesterase 9A in brain regulates cGMP signaling independent of nitric-oxide","volume":"13","author":"Harms","year":"2019","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0605","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.expneurol.2005.05.014","article-title":"Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus","volume":"195","author":"Hattiangady","year":"2005","journal-title":"Experimental Neurology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0610","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/bs.vh.2020.12.012_bb0615","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nlm.2014.10.011","article-title":"PDE and cognitive processing: Beyond the memory domain","volume":"119","author":"Heckman","year":"2015","journal-title":"Neurobiology of Learning and Memory"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb0620","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/npp.2016.106","article-title":"Phosphodiesterase 11A (PDE11A), enriched in ventral hippocampus neurons, is required for consolidation of social but not nonsocial memories in mice","volume":"41","author":"Hegde","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0625","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuroscience.2016.08.019","article-title":"PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain","volume":"335","author":"Hegde","year":"2016","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0630","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-017-0245-y","article-title":"Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression","volume":"9","author":"Hesse","year":"2017","journal-title":"Alzheimer's Research & Therapy"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0635","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000297","article-title":"Markers of cardiac dysfunction in cognitive impairment and dementia","volume":"94","author":"Hilal","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0640","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/07853890.2012.663929","article-title":"The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age","volume":"45","author":"Hiltunen","year":"2013","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0645","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/joim.12621","article-title":"Biomarkers of microvascular endothelial dysfunction predict incident dementia: A population-based prospective study","volume":"282","author":"Holm","year":"2017","journal-title":"Journal of Internal Medicine"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0650","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","article-title":"Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease","volume":"79","author":"Hu","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb0655","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1111\/j.1460-9568.2004.03796.x","article-title":"Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A","volume":"20","author":"Hu","year":"2004","journal-title":"The European Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0660","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jep.2006.11.016","article-title":"Enhanced cAMP\/PKA pathway by seabuckthorn fatty acids in aged rats","volume":"111","author":"Hu","year":"2007","journal-title":"Journal of Ethnopharmacology"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0665","doi-asserted-by":"crossref","first-page":"127097","DOI":"10.1016\/j.bmcl.2020.127097","article-title":"Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease","volume":"30","author":"Huang","year":"2020","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb0670","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00213-017-4587-8","article-title":"Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a","volume":"234","author":"Hufgard","year":"2017","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2020.12.012_bb0675","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0006-8993(01)02588-4","article-title":"Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain","volume":"907","author":"Ibarra","year":"2001","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089516","article-title":"Cilostazol add-on therapy in patients with mild dementia receiving donepezil: A retrospective study","volume":"9","author":"Ihara","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0685","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01276464","article-title":"Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases","volume":"100","author":"Ikeda","year":"1995","journal-title":"Journal of Neural Transmission. General Section"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb0690","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/j.1460-2075.1996.tb00604.x","article-title":"Negative transactivation of cAMP response element by familial Alzheimer's mutants of APP","volume":"15","author":"Ikezu","year":"1996","journal-title":"The EMBO Journal"},{"issue":"32","key":"10.1016\/bs.vh.2020.12.012_bb0695","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.2174\/0929867326666190620095623","article-title":"Multifunctional ligands targeting phosphodiesterase as the future strategy for the symptomatic and disease-modifying treatment of Alzheimer's disease","volume":"27","author":"Jankowska","year":"2019","journal-title":"Current Medicinal Chemistry"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0700","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0197-0186(02)00098-0","article-title":"Activation of constitutive nitric oxide synthase(s) and absence of inducible isoform in aged rat brain","volume":"42","author":"Jesko","year":"2003","journal-title":"Neurochemistry International"},{"issue":"17","key":"10.1016\/bs.vh.2020.12.012_bb0705","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1523\/JNEUROSCI.19-17-07486.1999","article-title":"cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease","volume":"19","author":"Jicha","year":"1999","journal-title":"The Journal of Neuroscience"},{"year":"2017","series-title":"Interventions to prevent age-related cognitive decline, mild cognitive impairment, and clinical Alzheimer\u2019s-type dementia","author":"Kane","key":"10.1016\/bs.vh.2020.12.012_bb0710"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0715","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2006.09.026","article-title":"Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity","volume":"144","author":"Kanes","year":"2007","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0720","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s12035-013-8582-8","article-title":"Switching responses: Spatial and temporal regulators of axon guidance","volume":"49","author":"Kaplan","year":"2014","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0725","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-160635","article-title":"N-terminal Pro-B Type natriuretic peptide is associated with mild cognitive impairment in the general population","volume":"55","author":"Kara","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2020.12.012_bb0730","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(01)02358-8","article-title":"Differential changes of cAMP-dependent protein kinase activity and 3H-cAMP binding sites in rat hippocampus during maturation and aging","volume":"315","author":"Karege","year":"2001","journal-title":"Neuroscience Letters"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2020.12.012_bb0735","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(01)02409-X","article-title":"A non-radioactive assay for the cAMP-dependent protein kinase activity in rat brain homogenates and age-related changes in hippocampus and cortex","volume":"903","author":"Karege","year":"2001","journal-title":"Brain Research"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0740","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1358\/mf.1998.20.5.485701","article-title":"Effect of rolipram on age-related changes in cyclic AMP-selective phosphodiesterase in the rat brain: An autoradiographic study","volume":"20","author":"Kato","year":"1998","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0745","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10048-016-0497-x","article-title":"Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson's disease revealed different epigenetic patterns in peripheral blood mononuclear cells","volume":"18","author":"Kaut","year":"2017","journal-title":"Neurogenetics"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0750","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2004.08.011","article-title":"Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease","volume":"26","author":"Kawamoto","year":"2005","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.vh.2020.12.012_bb0755","series-title":"Cyclic nucleotide phosphodiesterases in the central nervous system: From biology to disease","first-page":"47","article-title":"Putting together the pieces of phosphodiesterase distribution patterns in the brain: A jigsaw puzzle of cyclic nucleotide regulation","author":"Kelly","year":"2014"},{"key":"10.1016\/bs.vh.2020.12.012_bb0760","series-title":"Encyclopedia of signaling molecules","first-page":"3804","article-title":"PDE11A","author":"Kelly","year":"2018"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0765","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cellsig.2013.10.007","article-title":"Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain","volume":"26","author":"Kelly","year":"2014","journal-title":"Cellular Signalling"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0770","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.npp.1301099","article-title":"Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP","volume":"32","author":"Kelly","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/bs.vh.2020.12.012_bb0775","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.1073\/pnas.1000730107","article-title":"Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes","volume":"107","author":"Kelly","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0780","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mp.2008.124","article-title":"Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia","volume":"14","author":"Kelly","year":"2009","journal-title":"Molecular Psychiatry"},{"issue":"61","key":"10.1016\/bs.vh.2020.12.012_bb0785","first-page":"263","article-title":"Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease","author":"Kim","year":"2001","journal-title":"Journal of Neural Transmission. Supplementum"},{"key":"10.1016\/bs.vh.2020.12.012_bb0790","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2013.11.009","article-title":"Alpha-synuclein interferes with cAMP\/PKA-dependent upregulation of dopamine beta-hydroxylase and is associated with abnormal adaptive responses to immobilization stress","volume":"252","author":"Kim","year":"2014","journal-title":"Experimental Neurology"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb0795","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3390\/jcm8101751","article-title":"GSKIP-mediated anchoring increases phosphorylation of Tau by PKA but not by GSK3beta via cAMP\/PKA\/GSKIP\/GSK3\/Tau axis signaling in cerebrospinal fluid and iPS cells in Alzheimer disease","volume":"8","author":"Ko","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0800","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18388\/abp.2000_3975","article-title":"Particulate guanylyl cyclases: Multiple mechanisms of activation","volume":"47","author":"Kobialka","year":"2000","journal-title":"Acta Biochimica Polonica"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0805","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/WNR.0b013e328326f82f","article-title":"B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia","volume":"20","author":"Kondziella","year":"2009","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0810","first-page":"351","article-title":"Age-associated changes in content of cyclic adenosine-3', 5'-monophosphate (cAMP), cyclic guanosine-3',5'-monophosphate (cGMP) and in activity of phosphodiesterase-cAM (pDE-cAM) in spleen T-lymphocytes from C3HA mice","volume":"39","author":"Kostromin","year":"1984","journal-title":"Zeitschrift f\u00fcr Alternsforschung"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0815","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.neurobiolaging.2014.03.023","article-title":"PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition","volume":"35","author":"Kroker","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0820","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2005.06.045","article-title":"Age-related disturbance of memory and CREB phosphorylation in CA1 area of hippocampus of rats","volume":"1054","author":"Kudo","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/bs.vh.2020.12.012_bb0825","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pbb.2016.12.018","article-title":"Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia","volume":"153","author":"Kumar","year":"2017","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.vh.2020.12.012_bb0830","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.biopha.2017.01.059","article-title":"Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type","volume":"88","author":"Kumar","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2 and 3-Spec Issue","key":"10.1016\/bs.vh.2020.12.012_bb0835","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/FBP.0000000000000294","article-title":"Pharmacological activation of protein kinase A improves memory loss and neuropathological changes in a mouse model of dementia of Alzheimer's type","volume":"28","author":"Kumar","year":"2017","journal-title":"Behavioural Pharmacology"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb0840","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","article-title":"Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology","volume":"35","author":"Laurent","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0845","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0047-6374(97)01899-X","article-title":"cAMP signalling mechanisms with aging in the Ceratitis capitata brain","volume":"97","author":"Laviada","year":"1997","journal-title":"Mechanisms of Ageing and Development"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0850","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0306-4522(02)00082-9","article-title":"Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively unimpaired, and impaired Long-Evans rats","volume":"112","author":"Law","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0855","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12974-019-1649-3","article-title":"The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models","volume":"16","author":"Lee","year":"2019","journal-title":"Journal of Neuroinflammation"},{"issue":"7544","key":"10.1016\/bs.vh.2020.12.012_bb0860","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0865","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exger.2010.11.034","article-title":"Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats","volume":"46","author":"Leite","year":"2011","journal-title":"Experimental Gerontology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0870","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2012.11.016","article-title":"Phosphodiesterase 10A (PDE10A) localization in the R6\/2 mouse model of Huntington's disease","volume":"52","author":"Leuti","year":"2013","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.vh.2020.12.012_bb0875","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainres.2016.04.011","article-title":"Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-beta peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease","volume":"1642","author":"Li","year":"2016","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb0880","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1471-4159.2007.04942.x","article-title":"Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain","volume":"103","author":"Liang","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0885","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/MCB.01434-12","article-title":"Regulation of feedback between protein kinase A and the proteasome system worsens Huntington's disease","volume":"33","author":"Lin","year":"2013","journal-title":"Molecular and Cellular Biology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0890","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1159\/000493232","article-title":"Icariside II, a phosphodiesterase-5 inhibitor, attenuates beta-amyloid-induced cognitive deficits via BDNF\/TrkB\/CREB signaling","volume":"49","author":"Liu","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0895","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bcpt.12652","article-title":"Prophylactic melatonin attenuates isoflurane-induced cognitive impairment in aged rats through hippocampal melatonin receptor 2\u2014cAMP response element binding signalling","volume":"120","author":"Liu","year":"2017","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0900","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0306-4522(03)00210-0","article-title":"Regional variations and age-related changes in nitric oxide synthase and arginase in the sub-regions of the hippocampus","volume":"119","author":"Liu","year":"2003","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb0905","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neurobiolaging.2003.07.003","article-title":"Age-related changes in nitric oxide synthase and arginase in the rat prefrontal cortex","volume":"25","author":"Liu","year":"2004","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb0910","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/hipo.20085","article-title":"Hippocampal nitric oxide synthase and arginase and age-associated behavioral deficits","volume":"15","author":"Liu","year":"2005","journal-title":"Hippocampus"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0915","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WAD.0b013e31826d597a","article-title":"Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease","volume":"27","author":"Llano","year":"2013","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"15","key":"10.1016\/bs.vh.2020.12.012_bb0920","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1523\/JNEUROSCI.5018-12.2013","article-title":"Increases in cAMP, MAPK activity, and CREB phosphorylation during REM sleep: Implications for REM sleep and memory consolidation","volume":"33","author":"Luo","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.vh.2020.12.012_bb0925","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnagi.2019.00235","article-title":"High frequency repetitive transcranial magnetic stimulation alleviates cognitive impairment and modulates hippocampal synaptic structural plasticity in aged mice","volume":"11","author":"Ma","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"7","key":"10.1016\/bs.vh.2020.12.012_bb0930","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ncb1007","article-title":"Crosstalk between Rap1 and Rac regulates secretion of sAPPalpha","volume":"5","author":"Maillet","year":"2003","journal-title":"Nature Cell Biology"},{"issue":"8","key":"10.1016\/bs.vh.2020.12.012_bb0935","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acn3.79","article-title":"Phosphodiesterase III inhibitor promotes drainage of cerebrovascular beta-amyloid","volume":"1","author":"Maki","year":"2014","journal-title":"Annals of Clinical Translational Neurology"},{"key":"10.1016\/bs.vh.2020.12.012_bb0940","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4684-8893-7_13","article-title":"Biogenic amine-stimulated adenylate cyclase and spiroperidol-binding sites in rabbit brain: Evidence for selective loss of receptors with aging","volume":"113","author":"Makman","year":"1978","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0945","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(80)91017-3","article-title":"Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging","volume":"192","author":"Makman","year":"1980","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0950","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1021\/acschemneuro.7b00345","article-title":"Design, synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) for the treatment of Alzheimer's disease","volume":"9","author":"Mao","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"issue":"8","key":"10.1016\/bs.vh.2020.12.012_bb0955","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1007\/s11064-017-2233-9","article-title":"Post-natal deletion of neuronal cAMP responsive-element binding (CREB)-1 promotes pro-inflammatory changes in the mouse hippocampus","volume":"42","author":"Marchese","year":"2017","journal-title":"Neurochemical Research"},{"key":"10.1016\/bs.vh.2020.12.012_bb0960","doi-asserted-by":"crossref","first-page":"104506","DOI":"10.1016\/j.nbd.2019.104506","article-title":"Differential enhancement of ERK, PKA and Ca(2+) signaling in direct and indirect striatal neurons of Parkinsonian mice","volume":"130","author":"Mariani","year":"2019","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.vh.2020.12.012_bb0965","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.exger.2013.12.001","article-title":"Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study","volume":"50","author":"Marksteiner","year":"2014","journal-title":"Experimental Gerontology"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0970","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0006-8993(99)01981-2","article-title":"Increased cerebrospinal fluid cAMP levels in Alzheimer's disease","volume":"846","author":"Martinez","year":"1999","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb0975","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0006-8993(01)03009-8","article-title":"Increased cAMP immunostaining in cerebral vessels in Alzheimer's disease","volume":"922","author":"Martinez","year":"2001","journal-title":"Brain Research"},{"key":"10.1016\/bs.vh.2020.12.012_bb0980","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnbeh.2016.00166","article-title":"Activation of NO-cGMP signaling rescues age-related memory impairment in crickets","volume":"10","author":"Matsumoto","year":"2016","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb0985","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1471-4159.1999.0730532.x","article-title":"Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism","volume":"73","author":"Mattson","year":"1999","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb0990","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archneur.64.3.456","article-title":"Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease","volume":"64","author":"McLachlan","year":"2007","journal-title":"Archives of Neurology"},{"issue":"Pt. 6","key":"10.1016\/bs.vh.2020.12.012_bb0995","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1042\/BST0331330","article-title":"Cyclic nucleotide signalling: A molecular approach to drug discovery for Alzheimer's disease","volume":"33","author":"McPhee","year":"2005","journal-title":"Biochemical Society Transactions"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1000","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/1673-5374.200812","article-title":"Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders","volume":"12","author":"Mehan","year":"2017","journal-title":"Neural Regeneration Research"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1005","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1460-9568.2011.07606.x","article-title":"CREB in adult neurogenesis\u2014Master and partner in the development of adult-born neurons?","volume":"33","author":"Merz","year":"2011","journal-title":"The European Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JHD-140129","article-title":"Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6\/2 and BACHD mouse models of Huntington's disease","volume":"3","author":"Miller","year":"2014","journal-title":"Journal of Huntington's Disease"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jnnp-2014-309968","article-title":"The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: A 10-year follow-up study in the general population","volume":"87","author":"Mirza","year":"2016","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1006\/bbrc.1995.2537","article-title":"Age-dependent changes of NO synthase activity in the rat brain","volume":"215","author":"Mollace","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s12035-019-01745-z","article-title":"Phosphodiesterase 7 regulation in cellular and rodent models of Parkinson's disease","volume":"57","author":"Morales-Garcia","year":"2020","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1030","first-page":"E34","article-title":"Parkinson-related LRRK2 mutation R1441C\/G\/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3","volume":"111","author":"Muda","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"32","key":"10.1016\/bs.vh.2020.12.012_bb1035","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.1073\/pnas.1109297108","article-title":"Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling","volume":"108","author":"Muller","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2020.12.012_bb1040","doi-asserted-by":"crossref","first-page":"110822","DOI":"10.1016\/j.fct.2019.110822","article-title":"Phosphodiesterase inhibitors say NO to Alzheimer's disease","volume":"134","author":"Nabavi","year":"2019","journal-title":"Food and Chemical Toxicology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1447-0594.2009.00526.x","article-title":"Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease","volume":"9","author":"Naito","year":"2009","journal-title":"Geriatrics & Gerontology International"},{"key":"10.1016\/bs.vh.2020.12.012_bb1050","doi-asserted-by":"crossref","first-page":"112192","DOI":"10.1016\/j.bbr.2019.112192","article-title":"TAK-915, a phosphodiesterase 2A inhibitor, ameliorates the cognitive impairment associated with aging in rodent models","volume":"376","author":"Nakashima","year":"2019","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-510X(97)00267-0","article-title":"Cerebrospinal fluid cyclic guanosine 3'5' monophosphate levels in Parkinson's disease","volume":"155","author":"Navarro","year":"1998","journal-title":"Journal of the Neurological Sciences"},{"issue":"5573","key":"10.1016\/bs.vh.2020.12.012_bb1060","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.vh.2020.12.012_bb1065","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/acschemneuro.8b00014","article-title":"Novel tadalafil derivatives ameliorates scopolamine-induced cognitive impairment in mice via inhibition of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5)","volume":"9","author":"Ni","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"issue":"Pt. 10","key":"10.1016\/bs.vh.2020.12.012_bb1070","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/brain\/awv219","article-title":"Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease","volume":"138","author":"Niccolini","year":"2015","journal-title":"Brain"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1075","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1212\/WNL.0000000000004201","article-title":"Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits","volume":"89","author":"Niccolini","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.vh.2020.12.012_bb1080","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/ejn.12543","article-title":"Routes to cAMP: Shaping neuronal connectivity with distinct adenylate cyclases","volume":"39","author":"Nicol","year":"2014","journal-title":"The European Journal of Neuroscience"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1085","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1007\/s12035-016-0010-4","article-title":"Genome-wide analysis of RARbeta transcriptional targets in mouse striatum links retinoic acid signaling with Huntington's disease and other neurodegenerative disorders","volume":"54","author":"Niewiadomska-Cimicka","year":"2017","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000111994","article-title":"Homocysteine, cystatin C and N-terminal-pro brain natriuretic peptide. Vascular risk markers in elderly patients with mental illness","volume":"25","author":"Nilsson","year":"2008","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1095","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s12035-016-0355-8","article-title":"Can cyclic nucleotide phosphodiesterase inhibitors be drugs for Parkinson's disease?","volume":"55","author":"Nthenge-Ngumbau","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032664","article-title":"CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis","volume":"7","author":"Oeckl","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2020.12.012_bb1105","first-page":"501","article-title":"Reduced cAMP-signal transduction in postmortem hippocampus of demented old people","volume":"317","author":"Ohm","year":"1989","journal-title":"Progress in Clinical and Biological Research"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2020.12.012_bb1110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0006-8993(91)90512-T","article-title":"Reduced basal and stimulated (isoprenaline, Gpp(NH)p, forskolin) adenylate cyclase activity in Alzheimer's disease correlated with histopathological changes","volume":"540","author":"Ohm","year":"1991","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0197-4580(97)80307-7","article-title":"Decrease in adenylate cyclase activity antecedes neurofibrillary tangle formation","volume":"18","author":"Ohm","year":"1997","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1120","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jnc.12049","article-title":"Phosphodiesterase isoform-specific expression induced by traumatic brain injury","volume":"123","author":"Oliva","year":"2012","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(94)91017-0","article-title":"Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain","volume":"636","author":"O'Neill","year":"1994","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1130","doi-asserted-by":"crossref","first-page":"625 e611","DOI":"10.1016\/j.neurobiolaging.2011.03.018","article-title":"Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model","volume":"33","author":"Orejana","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/med.20177","article-title":"Cellular and molecular actions of Methylene Blue in the nervous system","volume":"31","author":"Oz","year":"2011","journal-title":"Medicinal Research Reviews"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb1140","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/mds.27733","article-title":"Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease","volume":"34","author":"Pagano","year":"2019","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.vh.2020.12.012_bb1145","doi-asserted-by":"crossref","first-page":"8363274","DOI":"10.1155\/2019\/8363274","article-title":"Modulation of phospho-CREB by systemically administered recombinant BDNF in the hippocampus of the R6\/2 mouse model of Huntington's disease","volume":"2019","author":"Paldino","year":"2019","journal-title":"Neuroscience Journal"},{"key":"10.1016\/bs.vh.2020.12.012_bb1150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2012.10.060","article-title":"Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory","volume":"240","author":"Palmeri","year":"2013","journal-title":"Behavioural Brain Research"},{"issue":"29","key":"10.1016\/bs.vh.2020.12.012_bb1155","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.3607-16.2017","article-title":"Amyloid-beta peptide is needed for cGMP-induced long-term potentiation and memory","volume":"37","author":"Palmeri","year":"2017","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/exnr.1999.7055","article-title":"Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism","volume":"157","author":"Paris","year":"1999","journal-title":"Experimental Neurology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1165","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2011.04.068","article-title":"Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid beta-induced cognitive deficits associated with decreased amyloid beta accumulation","volume":"408","author":"Park","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb1170","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/mp.2016.155","article-title":"PDE11A negatively regulates lithium responsivity","volume":"22","author":"Pathak","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1175","first-page":"179","article-title":"A reversal by L-arginine and sodium nitroprusside of ageing-induced memory impairment in rats by increasing nitric oxide concentration in the hippocampus","volume":"49","author":"Paul","year":"2005","journal-title":"Indian Journal of Physiology and Pharmacology"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb1180","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.neurobiolaging.2013.03.011","article-title":"Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease","volume":"34","author":"Perez-Gonzalez","year":"2013","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0014-4886(03)00042-6","article-title":"Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization","volume":"182","author":"Perez-Torres","year":"2003","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.vh.2020.12.012_bb1190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0531-5131(03)00104-3","article-title":"cAMP-specific phosphodiesterases expression in Alzheimer's disease brains","volume":"1251","author":"Perez-Torres","year":"2003","journal-title":"International Congress Series"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1195","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1101\/lm.541307","article-title":"The function of the glutamate-nitric oxide-cGMP pathway in brain in vivo and learning ability decrease in parallel in mature compared with young rats","volume":"14","author":"Piedrafita","year":"2007","journal-title":"Learning & Memory"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb1200","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.neurobiolaging.2007.03.023","article-title":"Alteration of CREB phosphorylation and spatial memory deficits in aged 129T2\/Sv mice","volume":"29","author":"Porte","year":"2008","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb1205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/13543784.2017.1364360","article-title":"Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease","volume":"26","author":"Prickaerts","year":"2017","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1210","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1523\/JNEUROSCI.2774-16.2016","article-title":"Pharmacological rescue of long-term potentiation in Alzheimer diseased synapses","volume":"37","author":"Prieto","year":"2017","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.vh.2020.12.012_bb1215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1326-6-60","article-title":"Downregulation of CREB expression in Alzheimer's brain and in Abeta-treated rat hippocampal neurons","volume":"6","author":"Pugazhenthi","year":"2011","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0047-6374(77)90006-9","article-title":"Effect of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum","volume":"6","author":"Puri","year":"1977","journal-title":"Mechanisms of Ageing and Development"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0047-6374(81)90132-9","article-title":"Age-related changes of cyclic nucleotide levels in rat brain regions","volume":"15","author":"Puri","year":"1981","journal-title":"Mechanisms of Ageing and Development"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1230","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.neurobiolaging.2013.09.002","article-title":"Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice","volume":"35","author":"Puzzo","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"25","key":"10.1016\/bs.vh.2020.12.012_bb1235","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model","volume":"29","author":"Puzzo","year":"2009","journal-title":"The Journal of Neuroscience"},{"issue":"29","key":"10.1016\/bs.vh.2020.12.012_bb1240","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1523\/JNEUROSCI.5291-04.2005","article-title":"Amyloid-beta peptide inhibits activation of the nitric oxide\/cGMP\/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity","volume":"25","author":"Puzzo","year":"2005","journal-title":"The Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1245","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ggi.12123","article-title":"Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease","volume":"14","author":"Qi","year":"2014","journal-title":"Geriatrics & Gerontology International"},{"key":"10.1016\/bs.vh.2020.12.012_bb1250","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejmech.2018.03.005","article-title":"Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease","volume":"150","author":"Rabal","year":"2018","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1255","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/acschemneuro.8b00648","article-title":"Discovery of in vivo chemical probes for treating Alzheimer's disease: Dual phosphodiesterase 5 (PDE5) and class I histone deacetylase selective inhibitors","volume":"10","author":"Rabal","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb1260","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1021\/acschemneuro.9b00303","article-title":"Multitarget approach for the treatment of Alzheimer's disease: Inhibition of phosphodiesterase 9 (PDE9) and histone deacetylases (HDACs) covering diverse selectivity profiles","volume":"10","author":"Rabal","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1265","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1006\/bbrc.1995.2571","article-title":"Hyperphosphorylation of the cytoskeletal protein Tau by the MAP-kinase PK40erk2: Regulation by prior phosphorylation with cAMP-dependent protein kinase A","volume":"215","author":"Raghunandan","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1270","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0896-6273(03)00694-9","article-title":"Dysregulation of protein kinase a signaling in the aged prefrontal cortex: New strategy for treating age-related cognitive decline.[see comment]","volume":"40","author":"Ramos","year":"2003","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/bs.vh.2020.12.012_bb1275","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1111\/j.1460-9568.2007.05589.x","article-title":"Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains","volume":"25","author":"Reyes-Irisarri","year":"2007","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.vh.2020.12.012_bb1280","doi-asserted-by":"crossref","first-page":"46320","DOI":"10.1038\/srep46320","article-title":"Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease","volume":"7","author":"Ricciarelli","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/19390211.2011.569514","article-title":"Cognitex supplementation in elderly adults with memory complaints: An uncontrolled open label trial","volume":"8","author":"Richter","year":"2011","journal-title":"Journal of Dietary Supplements"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1290","first-page":"256","article-title":"Phosphorylation of tau by cyclic-AMP-dependent protein kinase","volume":"4","author":"Robertson","year":"1993","journal-title":"Dementia"},{"key":"10.1016\/bs.vh.2020.12.012_bb1295","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fncel.2019.00432","article-title":"Phosphodiesterase-2 inhibitor Bay 60-7550 ameliorates Abeta-Induced cognitive and memory impairment via regulation of the HPA axis","volume":"13","author":"Ruan","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb1300","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaneurol.2014.1954","article-title":"The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease","volume":"71","author":"Russell","year":"2014","journal-title":"JAMA Neurology"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb1305","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.4103\/1673-5374.257523","article-title":"The role of LRRK2 on PKA-NFkappaB pathway in microglia cells: Implications for Parkinson's disease","volume":"14","author":"Russo","year":"2019","journal-title":"Neural Regeneration Research"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12974-018-1337-8","article-title":"Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4","volume":"15","author":"Russo","year":"2018","journal-title":"Journal of Neuroinflammation"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb1315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073664","article-title":"Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease","volume":"8","author":"Saavedra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2020.12.012_bb1320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1750-1326-7-50","article-title":"Hyperpolarization-activated cyclic nucleotide gated channels: A potential molecular link between epileptic seizures and Abeta generation in Alzheimer's disease","volume":"7","author":"Saito","year":"2012","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1447-0594.2012.00866.x","article-title":"Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: A pilot study","volume":"13","author":"Sakurai","year":"2013","journal-title":"Geriatrics & Gerontology International"},{"issue":"8","key":"10.1016\/bs.vh.2020.12.012_bb1330","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0006-3223(92)90296-C","article-title":"EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID","volume":"32","author":"Saletu","year":"1992","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1335","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1460-9568.2004.03566.x","article-title":"Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation","volume":"20","author":"Sancesario","year":"2004","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.vh.2020.12.012_bb1340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neuint.2014.10.004","article-title":"Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism?","volume":"79","author":"Sancesario","year":"2014","journal-title":"Neurochemistry International"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1345","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1155\/2009\/618619","article-title":"Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus","volume":"27","author":"Satoh","year":"2009","journal-title":"Disease Markers"},{"issue":"1\u20134","key":"10.1016\/bs.vh.2020.12.012_bb1350","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000333341","article-title":"CREB-regulated transcription coactivator 1-dependent transcription in Alzheimer's disease mice","volume":"10","author":"Saura","year":"2012","journal-title":"Neurodegenerative Diseases"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1355","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neurobiolaging.2004.08.013","article-title":"Age-related changes in cyclic GMP and PKG-stimulated cerebellar Na, K-ATPase activity","volume":"26","author":"Scavone","year":"2005","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(78)90070-7","article-title":"Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats","volume":"139","author":"Schmidt","year":"1978","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1365","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0006-8993(94)91692-6","article-title":"Adenylyl cyclase activity in Alzheimer's disease brain: Stimulatory and inhibitory signal transduction pathways are differently affected","volume":"644","author":"Schnecko","year":"1994","journal-title":"Brain Research"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb1370","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bi981874p","article-title":"Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments","volume":"38","author":"Schneider","year":"1999","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1375","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2011.01.036","article-title":"Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment","volume":"70","author":"Schneider","year":"2011","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1380","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell and Tissue Research"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1385","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1567205011666140505100858","article-title":"A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease","volume":"11","author":"Schwam","year":"2014","journal-title":"Current Alzheimer Research"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1390","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neurobiolaging.2005.03.024","article-title":"The cAMP-specific phosphodiesterase 4B mediates Abeta-induced microglial activation","volume":"27","author":"Sebastiani","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.vh.2020.12.012_bb1395","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuroscience.2014.12.008","article-title":"Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats","volume":"286","author":"Sharma","year":"2015","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1006977127422","article-title":"The order of exposure of tau to signal transduction kinases alters the generation of \"AD-like\" phosphoepitopes","volume":"19","author":"Shea","year":"1999","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"16","key":"10.1016\/bs.vh.2020.12.012_bb1405","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1074\/jbc.M110.204453","article-title":"Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: A mechanism involved in tau pathology of Alzheimer disease","volume":"286","author":"Shi","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1410","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s11357-012-9509-4","article-title":"Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging","volume":"35","author":"Shukitt-Hale","year":"2013","journal-title":"Age (Dordrecht, Netherlands)"},{"key":"10.1016\/bs.vh.2020.12.012_bb1415","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2012.06.048","article-title":"Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"64","author":"Sierksma","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.vh.2020.12.012_bb1420","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuropharm.2013.09.015","article-title":"Improvement of spatial memory function in APPswe\/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D","volume":"77","author":"Sierksma","year":"2014","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/bs.vh.2020.12.012_bb1425","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1007\/s12035-016-0129-3","article-title":"Neuroprotection through rapamycin-induced activation of autophagy and PI3K\/Akt1\/mTOR\/CREB signaling against amyloid-beta-induced oxidative stress, synaptic\/neurotransmission dysfunction, and neurodegeneration in adult rats","volume":"54","author":"Singh","year":"2017","journal-title":"Molecular Neurobiology"},{"issue":"39","key":"10.1016\/bs.vh.2020.12.012_bb1430","doi-asserted-by":"crossref","first-page":"16877","DOI":"10.1073\/pnas.0908706106","article-title":"Reversal of long-term dendritic spine alterations in Alzheimer disease models","volume":"106","author":"Smith","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb1435","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","article-title":"Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease","volume":"69","author":"Soares","year":"2012","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1440","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0306-3623(91)90237-Z","article-title":"Age-related changes of cyclic AMP phosphodiesterase activity in rat brain regions and a new phosphodiesterase inhibitor\u2014Nootropic agent adafenoxate","volume":"22","author":"Stancheva","year":"1991","journal-title":"General Pharmacology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1445","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.20402","article-title":"Subthalamic stimulation activates internal pallidus: Evidence from cGMP microdialysis in PD patients","volume":"57","author":"Stefani","year":"2005","journal-title":"Annals of Neurology"},{"issue":"70","key":"10.1016\/bs.vh.2020.12.012_bb1450","first-page":"401","article-title":"Deep brain stimulation in Parkinson's disease patients: Biochemical evidence","author":"Stefani","year":"2006","journal-title":"Journal of Neural Transmission. Supplementum"},{"issue":"2\u20133","key":"10.1016\/bs.vh.2020.12.012_bb1455","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2004.08.013","article-title":"Age-related alteration of activity and gene expression of endothelial nitric oxide synthase in different parts of the brain in rats","volume":"370","author":"Strosznajder","year":"2004","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1460","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(93)90428-P","article-title":"Age-related alteration in signal transduction: Involvement of the cAMP cascade","volume":"618","author":"Sugawa","year":"1993","journal-title":"Brain Research"},{"issue":"Suppl. 1","key":"10.1016\/bs.vh.2020.12.012_bb1465","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0167-4943(05)80069-X","article-title":"Signal transduction in aging","volume":"19","author":"Sugawa","year":"1994","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1470","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003119","article-title":"Vinpocetine for cognitive impairment and dementia","author":"Szatmari","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1475","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/psyg.12021","article-title":"Cilostazol improves cognitive function in patients with mild cognitive impairment: A retrospective analysis","volume":"13","author":"Taguchi","year":"2013","journal-title":"Psychogeriatrics"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1480","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12883-017-0800-y","article-title":"Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: A case control study","volume":"17","author":"Tai","year":"2017","journal-title":"BMC Neurology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1485","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s13311-017-0512-4","article-title":"Cilostazol use is associated with reduced risk of dementia: A nationwide cohort study","volume":"14","author":"Tai","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1490","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4049\/jimmunol.125.4.1665","article-title":"Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging normal humans and patients with Down's syndrome","volume":"125","author":"Tam","year":"1980","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1495","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI85594","article-title":"Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington's disease","volume":"127","author":"Tanaka","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1500","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12902","article-title":"Activation of MT2 receptor ameliorates dendritic abnormalities in Alzheimer's disease via C\/EBPalpha\/miR-125b pathway","volume":"18","author":"Tang","year":"2019","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1505","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1532-5415.1989.tb05682.x","article-title":"The safety and lack of efficacy of vinpocetine in Alzheimer's disease","volume":"37","author":"Thal","year":"1989","journal-title":"Journal of the American Geriatrics Society"},{"issue":"5","key":"10.1016\/bs.vh.2020.12.012_bb1510","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1042\/BST20190763","article-title":"Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches","volume":"47","author":"Tibbo","year":"2019","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/bs.vh.2020.12.012_bb1515","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroscience.2012.12.002","article-title":"Age-dependent alterations in cAMP signaling contribute to synaptic plasticity deficits following traumatic brain injury","volume":"231","author":"Titus","year":"2013","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1520","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1248\/bpb.19.300","article-title":"Influence of aging on rolipram-sensitive phosphodiesterase activity and [3H]rolipram binding in the rat brain","volume":"19","author":"Tohda","year":"1996","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"20","key":"10.1016\/bs.vh.2020.12.012_bb1525","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1074\/jbc.M010450200","article-title":"Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised","volume":"276","author":"Tong","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1530","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000017197","article-title":"Denbufylline in dementia: A double-blind controlled study","volume":"10","author":"Treves","year":"1999","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"7","key":"10.1016\/bs.vh.2020.12.012_bb1535","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1601-183X.2012.00836.x","article-title":"Inactivation of Pde8b enhances memory, motor performance, and protects against age-induced motor coordination decay","volume":"11","author":"Tsai","year":"2012","journal-title":"Genes, Brain, and Behavior"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1540","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00415-016-8378-7","article-title":"High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: The FINRISK study","volume":"264","author":"Tynkkynen","year":"2017","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1545","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3233\/JAD-141809","article-title":"NT-proBNP and the risk of dementia: A prospective cohort study with 14 years of follow-up","volume":"44","author":"Tynkkynen","year":"2015","journal-title":"Journal of Alzheimer's Disease"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1550","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3940(95)12288-5","article-title":"Protein kinase inhibitor attenuates apoptotic cell death induced by amyloid beta protein in culture of the rat cerebral cortex","volume":"203","author":"Ueda","year":"1996","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1555","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/nan.12203","article-title":"Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease","volume":"41","author":"Ugarte","year":"2015","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"3\u20134","key":"10.1016\/bs.vh.2020.12.012_bb1560","first-page":"115","article-title":"Study of the effects of vinpocetin on cognitive functions","volume":"65","author":"Valikovics","year":"2012","journal-title":"Ideggy\u00f3gy\u00e1szati Szemle"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1565","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1460-9568.1995.tb00673.x","article-title":"Age-related changes in the NMDA receptor\/nitric oxide\/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis","volume":"7","author":"Vallebuona","year":"1995","journal-title":"The European Journal of Neuroscience"},{"issue":"13","key":"10.1016\/bs.vh.2020.12.012_bb1570","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1212\/WNL.0000000000000820","article-title":"NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus study","volume":"83","author":"van Vliet","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1575","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.neurobiolaging.2012.10.006","article-title":"Working memory deficits and related disinhibition of the cAMP\/PKA\/CREB are alleviated by prefrontal alpha4beta2*-nAChRs stimulation in aged mice","volume":"34","author":"Vandesquille","year":"2013","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1580","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-122371","article-title":"Caffeine and cognitive decline in elderly women at high vascular risk","volume":"35","author":"Vercambre","year":"2013","journal-title":"Journal of Alzheimer's Disease"},{"issue":"25","key":"10.1016\/bs.vh.2020.12.012_bb1585","doi-asserted-by":"crossref","first-page":"14220","DOI":"10.1073\/pnas.2003277117","article-title":"cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases","volume":"117","author":"VerPlank","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2020.12.012_bb1590","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuroscience.2011.11.053","article-title":"Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons","volume":"202","author":"Vila-Luna","year":"2012","journal-title":"Neuroscience"},{"issue":"20","key":"10.1016\/bs.vh.2020.12.012_bb1595","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1073\/pnas.172504199","article-title":"Amyloid beta-peptide inhibition of the PKA\/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling","volume":"99","author":"Vitolo","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1600","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.36.1.89","article-title":"CSF cyclic nucleotides and somatostatin in Parkinson's disease","volume":"36","author":"Volicer","year":"1986","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.vh.2020.12.012_bb1605","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acschemneuro.9b00409","article-title":"WBQ5187, a multitarget directed agent, ameliorates cognitive impairment in a transgenic mouse model of Alzheimer's disease and modulates cerebral beta-amyloid, gliosis, cAMP levels, and neurodegeneration","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"issue":"14","key":"10.1016\/bs.vh.2020.12.012_bb1610","doi-asserted-by":"crossref","first-page":"17380","DOI":"10.18632\/oncotarget.8041","article-title":"The effect of resveratrol on beta amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1615","doi-asserted-by":"crossref","first-page":"543","DOI":"10.18632\/aging.102640","article-title":"Activation of alpha7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"7359","key":"10.1016\/bs.vh.2020.12.012_bb1620","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature10243","article-title":"Neuronal basis of age-related working memory decline","volume":"476","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2020.12.012_bb1625","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12035-016-0348-7","article-title":"Forskolin induces hyperphosphorylation of Tau accompanied by cell cycle reactivation in primary hippocampal neurons","volume":"55","author":"Wang","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb1630","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.neurobiolaging.2007.12.004","article-title":"Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP\/PKA signalling pathway","volume":"30","author":"Wang","year":"2009","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1635","doi-asserted-by":"crossref","first-page":"12044","DOI":"10.1038\/s41598-017-08070-2","article-title":"Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA\/PKG-dependent neuro-inflammatory and apoptotic pathways","volume":"7","author":"Wang","year":"2017","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1640","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S1461145711000836","article-title":"The phosphodiesterase-4 inhibitor rolipram reverses Abeta-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats","volume":"15","author":"Wang","year":"2012","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/bs.vh.2020.12.012_bb1645","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jns.2016.07.033","article-title":"Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers","volume":"368","author":"Wilson","year":"2016","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1650","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0306-4522(00)00243-8","article-title":"Guanosine 3',5'-cyclic monophosphate mediated inhibition of cell death induced by nerve growth factor withdrawal and beta-amyloid: Protective effects of propentofylline","volume":"99","author":"Wirtz-Brugger","year":"2000","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1655","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40478-020-00907-8","article-title":"Meta-analysis of human prefrontal cortex reveals activation of GFAP and decline of synaptic transmission in the aging brain","volume":"8","author":"Wruck","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"issue":"4","key":"10.1016\/bs.vh.2020.12.012_bb1660","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1159\/000495649","article-title":"Inhibition of microRNA-200a upregulates the expression of striatal dopamine receptor D2 to repress apoptosis of striatum via the cAMP\/PKA signaling pathway in rats with Parkinson's disease","volume":"51","author":"Wu","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/bs.vh.2020.12.012_bb1665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610219000383","article-title":"Genome-wide RNA sequencing analysis reveals that IGF-2 attenuates memory decline, oxidative stress and amyloid plaques in an Alzheimer's disease mouse model (AD) by activating the PI3K\/AKT\/CREB signaling pathway","volume":"31","author":"Xia","year":"2019","journal-title":"International Psychogeriatrics"},{"issue":"9","key":"10.1016\/bs.vh.2020.12.012_bb1670","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/gerona\/glq094","article-title":"Memory impairment in cognitively impaired aged rats associated with decreased hippocampal CREB phosphorylation: Reversal by procyanidins extracted from the lotus seedpod","volume":"65","author":"Xu","year":"2010","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/bs.vh.2020.12.012_bb1675","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2018.00204","article-title":"Inhibition of phosphodiesterase-4 reverses abeta-induced memory impairment by regulation of HPA axis related cAMP signaling","volume":"10","author":"Xu","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1680","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0925-4439(00)00083-1","article-title":"Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease","volume":"1535","author":"Yamamoto","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"issue":"6\u20137","key":"10.1016\/bs.vh.2020.12.012_bb1685","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF01291889","article-title":"Ca2+\/CaM-sensitive adenylyl cyclase activity is decreased in the Alzheimer's brain: Possible relation to type I adenylyl cyclase","volume":"104","author":"Yamamoto","year":"1997","journal-title":"Journal of Neural Transmission (Vienna)"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1690","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0006-8993(99)01220-2","article-title":"Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type","volume":"824","author":"Yamamoto-Sasaki","year":"1999","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/bs.vh.2020.12.012_bb1695","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1007\/s12035-018-1374-4","article-title":"PDE3 inhibitors repurposed as treatments for age-related cognitive impairment","volume":"56","author":"Yanai","year":"2019","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.vh.2020.12.012_bb1700","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuropharm.2016.12.006","article-title":"Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier","volume":"116","author":"Yanai","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1705","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.expneurol.2007.02.010","article-title":"Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV","volume":"211","author":"Yang","year":"2008","journal-title":"Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1710","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13055","article-title":"Tau inhibits PKA by nuclear proteasome-dependent PKAR2alpha elevation with suppressed CREB\/GluA1 phosphorylation","volume":"19","author":"Ye","year":"2020","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1715","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0306-4522(98)00383-2","article-title":"Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains","volume":"89","author":"Yew","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/bs.vh.2020.12.012_bb1720","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3389\/fphar.2018.01211","article-title":"Icariside II ameliorates cognitive impairments induced by chronic cerebral hypoperfusion by inhibiting the amyloidogenic pathway: Involvement of BDNF\/TrkB\/CREB signaling and up-regulation of PPARalpha and PPARgamma in rats","volume":"9","author":"Yin","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"10.1016\/bs.vh.2020.12.012_bb1725","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/npp.2011.107","article-title":"Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease","volume":"36","author":"Yiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.vh.2020.12.012_bb1730","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19358","article-title":"CREB overexpression in dorsal CA1 ameliorates long-term memory deficits in aged rats","volume":"6","author":"Yu","year":"2017","journal-title":"Elife"},{"issue":"11","key":"10.1016\/bs.vh.2020.12.012_bb1735","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/acschemneuro.7b00268","article-title":"Discovery of novel pyrazolopyrimidinone derivatives as phosphodiesterase 9A inhibitors capable of inhibiting butyrylcholinesterase for treatment of Alzheimer's disease","volume":"8","author":"Yu","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1740","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)01377-X","article-title":"Decrease of neuronal nitric oxide synthase in the cerebellum of aged rats","volume":"291","author":"Yu","year":"2000","journal-title":"Neuroscience Letters"},{"issue":"30","key":"10.1016\/bs.vh.2020.12.012_bb1745","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.febslet.2007.11.053","article-title":"Epac signaling pathway involves STEF, a guanine nucleotide exchange factor for Rac, to regulate APP processing","volume":"581","author":"Zaldua","year":"2007","journal-title":"FEBS Letters"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1750","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JAD-122236","article-title":"RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-beta42-induced memory deficits in mice","volume":"38","author":"Zhang","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.vh.2020.12.012_bb1755","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbr.2013.05.017","article-title":"Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP\/PS1 transgenic mice","volume":"250","author":"Zhang","year":"2013","journal-title":"Behavioural Brain Research"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb1760","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00702-005-0421-2","article-title":"A transitory activation of protein kinase-A induces a sustained tau hyperphosphorylation at multiple sites in N2a cells-imply a new mechanism in Alzheimer pathology","volume":"113","author":"Zhang","year":"2006","journal-title":"Journal of Neural Transmission (Vienna)"},{"issue":"16","key":"10.1016\/bs.vh.2020.12.012_bb1765","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1111\/bph.14377","article-title":"The phosphodiesterase 5 inhibitor, KJH-1002, reverses a mouse model of amnesia by activating a cGMP\/cAMP response element binding protein pathway and decreasing oxidative damage","volume":"175","author":"Zhang","year":"2018","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1770","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13054","article-title":"Activation of PKA\/SIRT1 signaling pathway by photobiomodulation therapy reduces Abeta levels in Alzheimer's disease models","volume":"19","author":"Zhang","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/bs.vh.2020.12.012_bb1775","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.peptides.2013.09.005","article-title":"Vasonatrin peptide, a novel protector of dopaminergic neurons against the injuries induced by n-methyl-4-phenylpyridiniums","volume":"49","author":"Zhao","year":"2013","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/bs.vh.2020.12.012_bb1780","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1432-1327.1998.2520542.x","article-title":"Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation","volume":"252","author":"Zheng-Fischhofer","year":"1998","journal-title":"European Journal of Biochemistry"},{"issue":"10","key":"10.1016\/bs.vh.2020.12.012_bb1785","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/bph.14983","article-title":"Roflupram exerts neuroprotection via activation of CREB\/PGC-1alpha signalling in experimental models of Parkinson's disease","volume":"177","author":"Zhong","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.vh.2020.12.012_bb1790","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2018.06.030","article-title":"Synaptic modification by L-theanine, a natural constituent in green tea, rescues the impairment of hippocampal long-term potentiation and memory in AD mice","volume":"138","author":"Zhu","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.vh.2020.12.012_bb1795","doi-asserted-by":"crossref","first-page":"146344","DOI":"10.1016\/j.brainres.2019.146344","article-title":"Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model","volume":"1722","author":"Zhu","year":"2019","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.vh.2020.12.012_bb1800","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0047-6374(74)90003-7","article-title":"Levels of adenosine 3',5'-cyclic monophosphate in the cerebral cortex of aging rats","volume":"3","author":"Zimmerman","year":"1974","journal-title":"Mechanisms of Ageing and Development"},{"issue":"2","key":"10.1016\/bs.vh.2020.12.012_bb1805","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0047-6374(75)90010-X","article-title":"Phosphodiesterase and adenyl-cyclase activities in the cerebral cotex of the aging rat","volume":"4","author":"Zimmerman","year":"1975","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/bs.vh.2020.12.012_bb1810","doi-asserted-by":"crossref","first-page":"113818","DOI":"10.1016\/j.bcp.2020.113818","article-title":"Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease","volume":"176","author":"Zuccarello","year":"2020","journal-title":"Biochemical Pharmacology"}],"container-title":["Vitamins and Hormones","Hormones and Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672920300601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672920300601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T17:18:25Z","timestamp":1753377505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672920300601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323855488"],"references-count":361,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2020.12.012","relation":{},"ISSN":["0083-6729"],"issn-type":[{"type":"print","value":"0083-6729"}],"subject":[],"published":{"date-parts":[[2021]]}}}